Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Family Medicine | Gastroenterology | Infections | Nursing | Pediatrics | Pharmacy | Critical Care | Emergency Medicine | Journal

Back to Journal Articles

New Rotavirus Vaccine Reduces Cases of Infant Diarrhea

Last Updated: June 15, 2011.

 

Moderately increased risk of intussusception following RV1 vaccination

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
In Mexico and Brazil, use of the new monovalent rotavirus vaccine is associated with a short-term risk of intussusception in vaccinated infants but prevents a far higher number of hospitalizations and deaths from diarrhea, according to a study published in the June 16 issue of the New England Journal of Medicine.

WEDNESDAY, June 15 (HealthDay News) -- In Mexico and Brazil, use of the new monovalent rotavirus vaccine (RV1) is associated with a short-term risk of intussusception in vaccinated infants but prevents a far higher number of hospitalizations and deaths from diarrhea, according to a study published in the June 16 issue of the New England Journal of Medicine.

Manish M. Patel, M.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues examined the association of RV1 with intussusception after routine immunization of infants. Observation at 69 hospitals (16 in Mexico and 53 in Brazil) identified 615 infants with intussusceptions (285 in Mexico and 330 in Brazil), who were enrolled together with 2,050 age-matched infants as controls.

The investigators found that, in Mexico, there was an increased risk of intussusception one to seven days after infants were given the first dose of RV1. Among infants in Brazil, there was no significant risk after the first dose, but after the second dose, the risk increased by a factor of 1.9 to 2.6, one to seven days after the second dose. A total of 96 annual extra cases of intussusception in Mexico and Brazil (approximately one per 51,000 infants and one per 68,000 infants, respectively), and five deaths from intussusception were ascribed to RV1. Conversely, approximately 80,000 hospitalizations and 1,300 deaths from diarrhea each year were prevented by RV1 in Mexico and Brazil.

"The absolute number of deaths and hospitalizations averted because of vaccination far exceeded the number of intussusception cases that may have been associated with vaccination," the authors write.

The editorial author disclosed financial relationships with the pharmaceutical industry.

Abstract
Full Text
Editorial

Copyright © 2011 HealthDay. All rights reserved.


Previous: Immunodeficient Patients May Be at Risk for Polio Next: New Meningococcal A Conjugate Vaccine Is Effective

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2013
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.